AGILENT TECHNOLOGIES, INC. 10-K

Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Our common stock is listed on the New York Stock Exchange with the ticker symbol “A”. As of December 2, 2020, there were 20,173 common stockholders of record. The information required by this item with respect to equity compensation plans is included under the caption " Equity Compensation Plans" in our Proxy Statement for the Annual Meeting of Stockholders to be held March 17, 2021, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A, and is incorporated herein by reference. STOCK PRICE PERFORMANCE GRAPH The graph below shows the cumulative total stockholder return on our common stock with the cumulative total return of the S&P 500 Index and our peer group, consisting of all companies in the Health Care and Materials Indexes of the S&P 500, assuming an initial investment of $100 on October 31, 2015 and the reinvestment of all dividends. Agilent’s stock price performance shown in the following graph is not indicative of future stock price performance. The data for this performance graph was compiled for us by Standard and Poor’s. INDEXED RETURNS Base Years Ending Period Company Name / Index 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 Agilent Technologies 100 116.63 183.87 176.70 208.42 283.31 S&P 500 100 104.51 129.21 138.70 158.57 173.97 Peer Group 100 99.21 123.71 134.82 147.29 163.88 28 Table of Contents ISSUER PURCHASES OF EQUITY SECURITIES The table below summarizes information about the company’s purchases, based on trade date, of its equity securities registered pursuant to Section 12 of the Exchange Act during the quarterly period ended October 31, 2020. The total number of shares of common stock purchased by the company during the fiscal year ended October 31, 2020 was 5,227,273 shares. Period Total Number of Shares of Common Stock Purchased(1) Weighted Average Price Paid per Share of Common Stock(2) Total Number of Shares of Common Stock Purchased as Part of Publicly Announced Plans or Programs(1) Maximum Approximate Dollar Value of Shares of Common Stock that May Yet Be Purchased Under the Plans or Programs (in millions)(1) August 1, 2020 through August 31, 2020 526,247 $ 98.38 526,247 $ 756 September 1, 2020 through September 30, 2020 1,041,643 $ 98.98 1,041,643 $ 653 October 1, 2020 through October 31, 2020 908,745 $ 104.62 908,745 $ 558 Total 2,476,635 $ 100.92 2,476,635 (1) On November 19, 2018 we announced that our board of directors had approved a new share repurchase program (the "2019 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2019 repurchase program authorizes the purchase of up to $1.75 billion of our common stock at the company's discretion and has no fixed termination date. As of October 31, 2020, we had remaining authorization to repurchase up to $558 million of our common stock under this program. The 2019 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. As of October 31, 2020, all repurchased shares have been retired. (2) The weighted average price paid per share of common stock does not include the cost of commissions. 29 Table of Contents Item 6. Selected Financial Data SELECTED FINANCIAL DATA (Unaudited) Years Ended October 31, 2020 2019 2018 2017 2016 (in millions, except per share data) Consolidated Statement of Operations Data: Net revenue (1) $ 5,339 $ 5,163 $ 4,914 $ 4,472 $ 4,202 Income before taxes $ 842 $ 919 $ 946 $ 803 $ 544 Net income (2) $ 719 $ 1,071 $ 316 $ 684 $ 462 Net income per share - Basic $ 2.33 $ 3.41 $ 0.98 $ 2.12 $ 1.42 Net income per share - Diluted $ 2.30 $ 3.37 $ 0.97 $ 2.10 $ 1.40 Weighted average shares used in computing net income per share: Basic 309 314 321 322 326 Diluted 312 318 325 326 329 Cash dividends declared per common share $ 0.720 $ 0.656 0.596 $ 0.528 $ 0.460 (1) In 2019 we adopted ASC Topic 606, Revenue from Contracts with Customers , using the modified retrospective approach. Results for reporting periods for 2019 and after are presented under ASC 606, while prior period amounts were not adjusted and continue to be reported in accordance with ASC Topic 605, Revenue Recognition . (2) Net income for the year ended October 31, 2019 was impacted by a tax benefit of $299 million related to the extension of tax incentives in Singapore. Net income for the year ended October 31, 2018 was impacted by a tax expense of $552 million related to the enactment of the U.S Tax Cuts and Jobs Act of 2017 (the "Tax Act"). October 31, 2020 2019 2018 2017 2016 (in millions) Consolidated Balance Sheet Data (1) : Cash and cash equivalents $ 1,441 $ 1,382 $ 2,247 $ 2,678 $ 2,289 Working capital $ 1,948 $ 1,109 $ 2,677 $ 2,906 $ 2,690 Total assets $ 9,627 $ 9,452 $ 8,541 $ 8,426 $ 7,794 Long-term debt $ 2,284 $ 1,791 $ 1,799 $ 1,801 $ 1,904 Stockholders' equity $ 4,873 $ 4,748 $ 4,567 $ 4,831 $ 4,243 (1) In 2020, we adopted ASC Topic 842, Leases , using the modified retrospective method. Results for reporting periods beginning November 1, 2019 are presented under ASC 842, while prior period amounts were not adjusted and are reported under ASC 840. 30 Table of Contents